Gemcitabine plus capecitabine compared with gemcitabine alone in advanced pancreatic cancer: a randomized, multicenter, phase III trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group (Q34579882)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Gemcitabine plus capecitabine compared with gemcitabine alone in advanced pancreatic cancer: a randomized, multicenter, phase III trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group |
scientific article |
Statements
1 reference
Gemcitabine plus capecitabine compared with gemcitabine alone in advanced pancreatic cancer: a randomized, multicenter, phase III trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group (English)
1 reference
Bengt Glimelius
1 reference
Richard Herrmann
1 reference
György Bodoky
1 reference
Thomas Ruhstaller
1 reference
Emilio Bajetta
1 reference
Johannes Schüller
1 reference
Piercarlo Saletti
1 reference
Jean Bauer
1 reference
Arie Figer
1 reference
Bernhard Pestalozzi
1 reference
Walter Mingrone
1 reference
Salomon M Stemmer
1 reference
Karin Tàmas
1 reference
Gabriela V Kornek
1 reference
Dieter Koeberle
1 reference
Susanne Cina
1 reference
Jürg Bernhard
1 reference
Daniel Dietrich
1 reference
Werner Scheithauer
1 reference
Swiss Group for Clinical Cancer Research
1 reference
Central European Cooperative Oncology Group
1 reference
1 June 2007
1 reference
1 reference
25
1 reference
16
1 reference
2212-2217
1 reference
Identifiers
1 reference
1 reference